CA2206423A1 - Agent antithrombotique et anticorps monoclonaux contre le facteur de von willebrand - Google Patents

Agent antithrombotique et anticorps monoclonaux contre le facteur de von willebrand

Info

Publication number
CA2206423A1
CA2206423A1 CA002206423A CA2206423A CA2206423A1 CA 2206423 A1 CA2206423 A1 CA 2206423A1 CA 002206423 A CA002206423 A CA 002206423A CA 2206423 A CA2206423 A CA 2206423A CA 2206423 A1 CA2206423 A1 CA 2206423A1
Authority
CA
Canada
Prior art keywords
von willebrand
willebrand factor
antithrombotic agent
monoclonal antibodies
action
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002206423A
Other languages
English (en)
Other versions
CA2206423C (fr
Inventor
Mitsuyo Nagano
Hiroshi Yamamoto
Morikazu Kito
Ryota Yoshimoto
Tsuyoshi Kobayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/JP1995/002435 external-priority patent/WO1996017078A1/fr
Publication of CA2206423A1 publication Critical patent/CA2206423A1/fr
Application granted granted Critical
Publication of CA2206423C publication Critical patent/CA2206423C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
CA002206423A 1994-11-30 1995-11-29 Agent antithrombotique et anticorps monoclonaux contre le facteur de von willebrand Expired - Fee Related CA2206423C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP29707094 1994-11-30
JP6-297070 1994-11-30
PCT/JP1995/002435 WO1996017078A1 (fr) 1994-11-30 1995-11-29 Agent antithrombotique et anticorps monoclonaux contre le facteur de von willebrand

Publications (2)

Publication Number Publication Date
CA2206423A1 true CA2206423A1 (fr) 1996-06-06
CA2206423C CA2206423C (fr) 2006-07-25

Family

ID=36707764

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002206423A Expired - Fee Related CA2206423C (fr) 1994-11-30 1995-11-29 Agent antithrombotique et anticorps monoclonaux contre le facteur de von willebrand

Country Status (1)

Country Link
CA (1) CA2206423C (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021258160A1 (fr) * 2020-06-26 2021-12-30 Monash University Anticorps anti-vwf et leurs utilisations

Also Published As

Publication number Publication date
CA2206423C (fr) 2006-07-25

Similar Documents

Publication Publication Date Title
EP0795608A4 (fr) Agent antithrombotique et anticorps monoclonaux contre le facteur de von willebrand
ES8101381A1 (es) Un procedimiento para la obtencion de un aglutinante para los tejidos a base de proteinas humanas o animales
ES8306023A1 (es) Procedimiento para la fabricacion de un aglutinante para tejidos a base de proteinas humanas o animales.
CA2159013A1 (fr) Gel a raser en atomiseur
ES8101382A1 (es) Un procedimiento para la obtencion de un aglutinante para los tejidos a base de proteinas humanas o animales
AU556068B2 (en) Fibrinogen formulation into tissue adhesive and intravenous concentrate
EP0550528A4 (en) Active site of interleukin-8: polypeptide analogs and antibodies
FI970747A0 (fi) Yhdistelmävalmiste käytettäväksi immunologisissa sairauksissa
IL56405A (en) Substituted n-phenyl-n'-(2-chloro-6-fluoro-benzoyl)-ureas,their preparation and their use as insecticides
FI935304A7 (fi) Ionisten, samepistettä modifioivien aineiden käyttö hiukkasten kasautumisen estämiseen steriloinnin aikana
MY117090A (en) Substituted benzamidines, their preparation and their use as pharmaceutical compounds
AU4626389A (en) Use of minoxidil for wound healing
CA2055695A1 (fr) Antigene immunoreactif s'apparentant au ca 195 tire du liquide amniotique humain
IT1224574B (it) Fattore di attivazione di leucociti neutrofili, procedimento di preparazione, nonche' composizioni farmaceutiche che lo contengono
ZA91115B (en) Topical compositions
FR2714603B1 (fr) Composition dermatologique et son utilisation pour la préparation d'un médicament.
ATE25195T1 (de) Verwendung von d,l- und d-carazolol zur herstellung von antiglaukommitteln sowie arzneimittel, die d-carazolol enthalten.
IL70361A0 (en) 3'5'-diarabinosides,their preparation and their application in therapy
WO1992022299A3 (fr) Utilisation d'agents anti-arythmiques dans l'abaissement du cholesterol
FR2549835B1 (fr) Acides peneme-carboxyliques, leur preparation et leur utilisation therapeutique, notamment en tant qu'agents antibacteriens
EP0089198A3 (fr) Composition non toxique contenant de l'aspirine
AU2065488A (en) The preparation of antigens of human immunodeficiency virus type 1, and the use thereof as diagnostic and therapeutic agent
RU95118793A (ru) Ранозаживляющее средство "фрам"
JPS602542U (ja) 防腐剤入り生理用品
UA43389C2 (uk) Спосіб зниження рівнів кальцію у сироватці

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20141201